Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Conditioned medium from treated cells boosts hair growth in mice.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

Abatacept may help some people with alopecia areata regrow hair.

Cetuximab can cause skin cysts after acne-like eruptions.

The combination treatment showed a higher response rate but no significant survival benefits.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Cell adhesion molecules are important in the development of certain skin diseases.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Apremilast may help treat hair loss in alopecia areata.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Dupilumab can both heal and cause hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.